Stem Cell Therapy for Erectile Dysfunction Tissue Regeneration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for erectile dysfunction (ED) are inadequate, as many patients are unresponsive to phosphodiesterase type 5 (PDE5) inhibitors, experience adverse effects, or have vascular and neurologic conditions that prevent effective treatment, and existing methods do not address the underlying physiological causes of ED.
Innovation Solution
Administration of CD34+ bone marrow-derived stem cells to induce endothelial responsiveness and nitric oxide production, combined with testosterone therapy to promote smooth muscle cell growth, to regenerate erectile tissue and improve blood flow, thereby addressing the underlying causes of ED.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If phosphodiesterase type 5 (PDE5) inhibitors are used to treat ED, then erectile function is improved in some patients, but many patients are unresponsive, experience adverse effects, or have conditions that prevent effective treatment
Solution Approach 1:
The patent introduces stem cells as an intermediary therapeutic agent that addresses the underlying physiological causes of ED (endothelial dysfunction, smooth muscle degeneration, neurologic impairment) rather than merely treating symptoms. These stem cells differentiate into functional tissue components and secrete paracrine factors that restore normal erectile physiology, providing a universal treatment mechanism that works across diverse patient populations regardless of their response to PDE5 inhibitors.
Solution Approach 2:
The stem cell therapy enables the patient's own body to regenerate functional erectile tissue through the transplanted cells' ability to differentiate into endothelial cells, smooth muscle cells, and neuronal cells. The cells also secrete growth factors and cytokines that stimulate endogenous repair mechanisms, allowing the tissue to self-renew and restore function without continuous external pharmacological intervention.
2Reliability
If PDE5 inhibitors are used as standard treatment, then some patients achieve improved erectile function, but numerous patients experience adverse effects or do not tolerate treatment
Solution Approach 1:
Stem cells serve as a biological mediator that restores endothelial function and nitric oxide production at the cellular level, addressing the root cause of ED rather than interfering with the PDE5 enzyme pathway. This mechanism avoids the systemic side effects associated with PDE5 inhibition while achieving reliable improvement in erectile function through physiological tissue regeneration.
3Ease of operation
If traditional pharmacological methods are used to treat ED, then symptomatic relief is achieved, but the underlying physiological causes of ED are not addressed
Solution Approach 1:
The stem cells autonomously differentiate into functional tissue components and secrete paracrine factors that restore normal erectile physiology. This self-service mechanism addresses the underlying physiological causes (endothelial dysfunction, smooth muscle degeneration, neurologic impairment) while maintaining treatment simplicity through a single administration or limited dosing schedule, eliminating the need for continuous pharmacological intervention.
Data Source
AI summary
Methods, cells and compositions of matter are provided for treatment of erectile dysfunction using stem cell therapy. In particular, various stem cells are modified or administered freshly isolated in order to induce smooth muscle regeneration, neural regeneration, and restoration of endothelial function. In some embodiments endogenous stem cells are mobilized or activated to achieve therapeutic benefit. In other embodiments compositions derived from stem cells are utilized for treatment of erectile dysfunction.